| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2026 | 20 May 2026 |
| Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Dear Sir/Madam Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 we wish to inform you that Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday the 27th day of May 2026 to discuss the following items: 1. To Consider and Approve the Audited Standalone & Consolidated Financial Statement of the Company for the Quarter/Year ended March 31 2026. 2. Any other matters with the permission of the Chairman. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for prevention of Insider Trading and Code of Corporate Disclosure Practices We wish to inform you that the Trading Window for dealing in the Equity Shares of the Company has remained closed for all Designated Person and their Immediate Relatives w.e.f. April 01 2026 till the conclusion of 48 hours after the declaration of Financial Results of the Company for the Quarter/Year ended March 31 2026. | ||
| Board Meeting | 13 Feb 2026 | 4 Feb 2026 |
| Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited Consolidated & Standalone Financial Results of the company for the Quarter ended 31st December 2025. Any other matters with the permission of the Chairman. The Board of Directors at their meeting held on 13th February 2026 have approved unaudited Consolidated & Standalone Financial Results for the Quarter ended 31st December 2025. This is to inform you that the Board of Directors at their meeting held on Friday, February 13, 2026, have Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended December 31, 2025. (As per BSE announcement dated on : 13.02.2026) | ||
| Board Meeting | 3 Jan 2026 | 3 Jan 2026 |
| This is to inform you that under Regulation 30(9) of SEBI (LODR) Regulations, 2015 with reference to our earlier intimation dated September 30,2025, Natural Biogenex Private Limited (Material Subsidiary), at its Board meeting held on today i.e. January 03, 2026 has decided not to proceed with the allotment of shares under the Rights Issue due to the non-subscription by the major shareholder. | ||
| Board Meeting | 13 Nov 2025 | 3 Nov 2025 |
| Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Un-audited Consolidated and Standalone Financial Results of the Company for the Quarter and half year ended 30th September 2025 Outcome of Board Meeting Un-audited Financials for the Quarter and half year ended 30th September 2025 Outcome of Board Meeting (As Per BSE Announcement Dated on:13.11.2025) | ||
| Board Meeting | 30 Sep 2025 | 30 Sep 2025 |
| Intimation under Regulation 30(9) of SEBI (LODR) Regulations, 2015 | ||
| Board Meeting | 4 Aug 2025 | 28 Jul 2025 |
| Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Unaudited Consolidated & Standalone Financial Results of the company for the Quarter ended 30th June, 2025. Outcome of Board Meeting held on Monday, August 04, 2025 Please find enclosed Unaudited Consolidated and Standalone Financial Results for the Quarter ended 30th June 2025 (As Per BSE Announcement Dated on :04.08.2025) | ||
| Board Meeting | 29 May 2025 | 22 May 2025 |
| Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1.Audited Consolidated & Standalone Financial Results of the company for theQuarter & Financial Year ended March 31st 2025 2.Any other matters with the permission of the Chairman. We request you to kindly take the aforesaid information on record for dissemination through your website This is to inform that the board of directors at their meeting held on Thursday, May 29th 2025 have approved the Audited standalone & consolidated financial results for the quarter and year ended 31st March 2025 (As per BSE Announcement Dated on 29/05/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
